about
Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy.Antiviral drugs for viruses other than human immunodeficiency virusAntiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapyA 33-year-old man with a facial rashAnti-flavivirus Activity of Different Tritylated Pyrimidine and Purine Nucleoside AnaloguesMarine Sponges as a Drug TreasureTherapeutic potential of TAS-102 in the treatment of gastrointestinal malignanciesRole of Marine Natural Products in the Genesis of Antiviral AgentsSynergizing vaccinations with therapeutics for measles eradicationTetraspanins in viral infections: a fundamental role in viral biology?Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretroviralsA polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activityThe Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal ApplicationsStructure of the Varicella Zoster Virus Thymidylate Synthase Establishes Functional and Structural Similarities as the Human Enzyme and Potentiates Itself as a Target of BrivudineTwo years after pandemic influenza A/2009/H1N1: what have we learned?Antiviral therapy of influenza.In vitro Cytotoxicity and Anti-herpes Simplex Virus Type 1 Activity of Hydroethanolic Extract, Fractions, and Isolated Compounds from Stem Bark of Schinus terebinthifolius Raddi.Interferon-resistant Daudi cell line with a Stat2 defect is resistant to apoptosis induced by chemotherapeutic agents.Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients.A rapid synthetic route to conformationally restricted [5,5]-bicyclic nucleoside-amino acid conjugates.Structure-based design, synthesis and biological evaluation of new N-carboxyphenylpyrrole derivatives as HIV fusion inhibitors targeting gp41.Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1.Norovirus proteinase-polymerase and polymerase are both active forms of RNA-dependent RNA polymeraseOptimal management of cytomegalovirus retinitis in patients with AIDS.Solid-Phase Synthesis of 5'-O-β,γ-Methylenetriphosphate Derivatives of Nucleosides and Evaluation of Their Inhibitory Activity Against HIV-1 Reverse Transcriptase.Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.Comprehensive bioinformatic analysis of the specificity of human immunodeficiency virus type 1 protease.Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir.Determination of imidol hydrochloride in human plasma and urine by high-performance liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetic study.High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses.Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.Enterovirus infection in Korean children and anti-enteroviral potential candidate agents.Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancerTherapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.Enhanced replication of R5 HIV-1 isolates in vitro by a small-molecule reagent targeting HIV-1 protease.Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs.
P2860
Q24537618-08B1303E-3807-40A9-AB30-5D59DFE05C61Q24542846-21F92617-F421-4BAD-9E2F-7B75B391BE0CQ24635330-D7A5535C-94A4-43B9-8F4A-411C6DD4C30AQ24672068-7DB9249D-3F17-46B7-B7E4-6B28FDFCBC85Q24796579-B47B2C17-44F3-493F-AA2F-10E6FB413A5CQ26700072-571B1298-7893-4324-BA89-8749CD851DF2Q26746939-4B78C7DB-3E73-402F-A86D-FC5B3FE4B305Q26777679-537DD70A-EE61-4A4C-AD2F-67806A521798Q26796360-188D7EF8-3710-4B3C-A7AA-7F72BF052A90Q27003149-CDD47DE3-5BB0-4B4B-BAC3-4664B4F517DAQ27470936-33B0D780-1DAE-4290-89E5-2BEFF470FFB3Q28469262-630E651A-5B58-4453-A8BB-163AD8441C32Q28533996-73448C2D-DBF1-4FCE-B74F-B812D65B6344Q28546014-F1C08A85-F9B5-4F84-9C70-3128EEE6CEB2Q28551253-4AB117C5-1732-4933-BACC-7453698920BEQ30224656-AAE6A917-6F04-4FAC-9CAB-26DE23A41191Q30350565-F4E63B3F-5B31-4D93-8661-342472F9F1AAQ31076765-9363C4FF-6655-4FAC-BDC7-708037EB1C47Q31083397-D18C358E-8366-460A-B314-44A82676945DQ33273039-F95B413B-D6DF-4364-9F44-FBC1999ADAD8Q33359427-1446B498-68C7-4A93-B5FC-28197BC851A8Q33638192-97D1455F-1CAC-4AF6-B721-A3D92A22CC94Q33710923-FD8CA2A1-D400-407B-AF67-8279BCF4D3CBQ33712662-8E39D2F7-0494-43BF-BE81-9A3389CE8F19Q33781094-3DB51FD5-34D5-4C95-BC63-FDC6F382E6DFQ33819834-9407ECC6-D0B2-4393-A22A-08D3CA6F14C7Q33831172-E002FA7A-E8B5-439B-B0AE-26924D15DDC6Q33935329-342C67A5-CA59-4ACB-A045-E7660DF01271Q33984365-B0EA00C9-1A4F-4B31-B71D-1A8C4D282152Q34073558-79A9DABC-18EF-4240-B57A-98950D8881DCQ34228643-64A66BB9-4822-4373-999E-48CF0E5C1D64Q34230693-AE163E73-CB39-4CE6-A9B3-F4DD9A7D2308Q34303603-A8E38BC1-D3DC-40F8-A74E-99398155ACB7Q34352431-61C0B540-7423-4C14-A14C-02BA756EA55BQ34464333-F93F2DC8-4B3A-461F-A4FE-A9AAD30DFDF8Q34469094-90AA6464-D866-4E42-A359-36252276B446Q34481269-E2A1BDCB-8203-400E-A310-60AE70714B35Q34620205-770C38B6-25DF-490D-B798-6D3187BF59ABQ34627166-29AC06AF-437D-4795-AF5C-B6E1CBF5DDFBQ34677656-F7E168EE-7C91-4E8B-BDD8-9C3C10F4222D
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Antiviral drugs in current clinical use.
@ast
Antiviral drugs in current clinical use.
@en
Antiviral drugs in current clinical use.
@nl
type
label
Antiviral drugs in current clinical use.
@ast
Antiviral drugs in current clinical use.
@en
Antiviral drugs in current clinical use.
@nl
prefLabel
Antiviral drugs in current clinical use.
@ast
Antiviral drugs in current clinical use.
@en
Antiviral drugs in current clinical use.
@nl
P1476
Antiviral drugs in current clinical use.
@en
P304
P356
10.1016/J.JCV.2004.02.009
P577
2004-06-01T00:00:00Z